Literature DB >> 13781801

Morphologic alterations produced by copper in neural tissues with consideration of the role of the metal in the pathogenesis of Wilson's disease.

F S VOGEL, J W EVANS.   

Abstract

The injection into the cerebrospinal fluid of cats of 52 to 208 gamma of copper in the form of an albumin complex or as cupric sulfate, was followed by small elevations in the content of metal in the neural tissues, but regularly and promptly produced persistent quadriplegia and conspicuous histologic changes. Smaller amounts of copper caused less, or no, neurologic manifestations or histologic alterations. The earliest lesions were essentially unaccompanied by inflammation and were initially characterized by hydropic swelling of the myelin sheaths. They progressed rapidly to focal necrosis of all parenchymal components with marked degeneration of myelin and axis cylinders in the peripheral margins of the spinal cord, brain stem, mid-brain, and cerebrum. These histologic changes did not occur in neural tissues incubated in vitro in solutions of the copper-albumin complex. They did not appear in animals injected intraventricularly with ferric sulfate or saccharated iron. Considered together, the findings make it clear that copper in concentrations comparable to those present in the neural tissues of patients with Wilson's disease has the property of profoundly altering neural function and causing conspicuous morphologic alterations.

Entities:  

Keywords:  COPPER/toxicology; HEPATOLENTICULAR DEGENERATION/experimental; NERVOUS SYSTEM/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 13781801      PMCID: PMC2137425          DOI: 10.1084/jem.113.6.997

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  Penetration of radioactive bovine albumin from cerebrospinal fluid into brain tissue.

Authors:  J C LEE; J OLSZEWSKI
Journal:  Neurology       Date:  1960-09       Impact factor: 9.910

2.  Histochemical localization of copper with rubeanic acid.

Authors:  L L UZMAN
Journal:  Lab Invest       Date:  1956 May-Jun       Impact factor: 5.662

3.  Micro-determination of copper in biological material.

Authors:  A Eden; H H Green
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

4.  Nephrotoxic Properties of Copper under Experimental Conditions in Mice: With Special Reference to the Pathogenesis of the Renal Alterations in Wilson's Disease.

Authors:  F S Vogel
Journal:  Am J Pathol       Date:  1960-06       Impact factor: 4.307

5.  THE DEPOSITION OF EXOGENOUS COPPER UNDER EXPERIMENTAL CONDITIONS WITH OBSERVATIONS ON ITS NEUROTOXIC AND NEPHROTOXIC PROPERTIES IN RELATION TO WILSON'S DISEASE.

Authors:  F S Vogel
Journal:  J Exp Med       Date:  1959-10-31       Impact factor: 14.307

  5 in total
  10 in total

Review 1.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

2.  Morphology and histochemistry of Wilsonian and hepatogenic gliopathy in tissue culture.

Authors:  M J Mossakowski; K Renkawek; Z Kraśnicka; M Smialek; A Pronaszko
Journal:  Acta Neuropathol       Date:  1970       Impact factor: 17.088

3.  Chronic copper poisoning and changes in the central nervous system of sheep.

Authors:  J M Howell; W F Blakemore; C Gopinath; G A Hall; J H Parker
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

4.  Studies on azide, caeruloplasmin and copper in relation to Wilson's disease.

Authors:  A O Williams
Journal:  Br J Exp Pathol       Date:  1967-04

5.  [Ceruloplasmin and copper metabolism in multiple sclerosis].

Authors:  H Bammer
Journal:  Dtsch Z Nervenheilkd       Date:  1966-10-24

6.  Pearls & Oy-sters: Challenges and Controversies in Wilson Disease.

Authors:  Marta Ruiz-Lopez; Ana Moreno Estébanez; Beatriz Tijero; Tamara Fernandez; Alba Rebollo-Perez; Iñigo Gabilondo; Nuria Lopez-Osle; Leticia Ceberio-Hualde; Juan Jose Zarranz; Juan Carlos Gomez-Esteban
Journal:  Neurology       Date:  2022-06-13       Impact factor: 11.800

7.  Increased Magnetic Susceptibility in the Deep Gray Matter Nuclei of Wilson's Disease: Have We Been Ignoring Atrophy?

Authors:  Xiao-Zhong Jing; Xiang-Zhen Yuan; Gai-Ying Li; Jia-Lin Chen; Rong Wu; Ling-Li Yang; Shu-Yun Zhang; Xiao-Ping Wang; Jian-Qi Li
Journal:  Front Neurosci       Date:  2022-06-01       Impact factor: 5.152

8.  Bis-choline tetrathiomolybdate prevents copper-induced blood-brain barrier damage.

Authors:  Sabine Borchard; Stefanie Raschke; Krzysztof M Zak; Carola Eberhagen; Claudia Einer; Elisabeth Weber; Sandra M Müller; Bernhard Michalke; Josef Lichtmannegger; Albrecht Wieser; Tamara Rieder; Grzegorz M Popowicz; Jerzy Adamski; Martin Klingenspor; Andrew H Coles; Ruth Viana; Mikkel H Vendelbo; Thomas D Sandahl; Tanja Schwerdtle; Thomas Plitz; Hans Zischka
Journal:  Life Sci Alliance       Date:  2021-12-02

9.  Friedreich's ataxia causes redistribution of iron, copper, and zinc in the dentate nucleus.

Authors:  Arnulf H Koeppen; R Liane Ramirez; Devin Yu; Sarah E Collins; Jiang Qian; Patrick J Parsons; Karl X Yang; Zewu Chen; Joseph E Mazurkiewicz; Paul J Feustel
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

Review 10.  Subcellular Localization of Copper-Cellular Bioimaging with Focus on Neurological Disorders.

Authors:  Barbara Witt; Dirk Schaumlöffel; Tanja Schwerdtle
Journal:  Int J Mol Sci       Date:  2020-03-28       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.